Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 20 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Manika, Aikaterini  [Clear All Filters]
Journal Article
Manika, A., Kipourou M., Georga S., Faniadou E., Pilianidis G., Arsos G., et al. (2020).  18F-FDG PET/CT contribution to tuberculous vertebral osteomyelitis diagnosis: a case report.. Oxf Med Case Reports. 2020(9), omaa068.
Manika, A., Hatziagorou E., Kotoulas S-C., Kyrvasili S-S., Sourla E., Kouroukli E., et al. (2022).  Adherence to inhaled therapies over 4 years in people with cystic fibrosis.. Pediatr Pulmonol. 57(4), 956-964.
Günther, G., Guglielmetti L., Leu C., Lange C., van Leth F., Hafizi H., et al. (2023).  Availability and costs of medicines for the treatment of tuberculosis in Europe. Clinical Microbiology and Infection. 29(1), 77 - 84.
Manika, A., Domvri K., Kyriazis G., Kontakiotis T., & Papakosta D. (2022).  BALF and BLOOD NK- cells in different stages of pulmonary sarcoidosis.. Sarcoidosis Vasc Diffuse Lung Dis. 38(4), e2021039.
Toesca, A., Botteri E., Lazzeroni M., Vila J., Manika A., Ballardini B., et al. (2014).  Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence.. Breast. 23(6), 829-35.
Migliori, G. Battista, Thong P. Min, Alffenaar J-W., Denholm J., Tadolini M., Alyaquobi F., et al. (2022).  Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study.. J Bras Pneumol. 48(2), e20220087.
Borisov, S. E., Dheda K., Enwerem M., Leyet R. Romero, D'Ambrosio L., Centis R., et al. (2017).  Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. European Respiratory Journal. 49(5), 1700387.
Balassoulis, G., Sichletidis L., Spyratos D., Chloros D., Zarogoulidis K., Kontakiotis T., et al. (2008).  Efficacy and Safety of Erythromycin as Sclerosing Agent in Patients With Recurrent Malignant Pleural Effusion. American Journal of Clinical Oncology. 31(4), 384 - 389.
Kontou, P., Kotoulas S-C., Kalliontzis S., Synodinos-Kamilos S., Akritidou S., Kaimakamis E., et al. (2023).  Evaluation of Pain Scales and Outcome in Critically Ill Patients of a Greek ICU.. J Pain Palliat Care Pharmacother. 37(1), 34-43.
van den Elsen, S. H. J., Sturkenboom M. G. G., Akkerman O. W., Manika A., Kioumis I. P., van der Werf T. S., et al. (2019).  Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis PatientsABSTRACT. Antimicrobial Agents and Chemotherapy. 63(7), 
Boutou, A., Manika A., Hajimitrova M., Pitsiou G., Giannakopoulou P., Sourla E., et al. (2020).  Longitudinal Changes in Exercise Capacity among Adult Cystic Fibrosis Patients. Advances in Respiratory Medicine. 88(5), 420 - 423.
Sionidou, M., Manika A., Pitsiou G., Kontou P., Chatzika K., Zarogoulidis P., et al. (2019).  Moxifloxacin in Chronic Obstructive Pulmonary Disease: Pharmacokinetics and Penetration into Bronchial Secretions in Ward and Intensive Care Unit PatientsABSTRACT. Antimicrobial Agents and Chemotherapy. 63(3), 
Papaventsis, D., Dougas G., Kalkouni O., Karabela S., & Manika A. (2021).  Occupational Exposure to Zoonotic Tuberculosis Caused by Mycobacterium caprae, Northern Greece, 2019.. Emerg Infect Dis. 27(7), 1997-1999.
van den Elsen, S. H. J., Sturkenboom M. G. G., Akkerman O., Barkane L., Bruchfeld J., Eather G., et al. (2020).  Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT). BMJ Open. 10(6), e035350.
Hatziagorou, E., Manika A., Kyrvasili S. Styliani, Kotoulas S. Chrysovala, Chrysochoou E. Anna, Kouroukli E., et al. (2022).  Pulmonary medication adherence among children and adults with cystic fibrosis: Is there an association with disease severity?. Pediatr Pulmonol. 57(12), 3017-3026.
Kotoulas, S. Chrysovala, Manika A., Pilianidis G., Tsikouriadis P., Kalopitas G., Petridis N., et al. (2019).  A rare pulmonary pathology complicated with an unusual condition. Breathe. 15(2), 121 - 127.
Iacovides, A., Fountoulakis K. N., Balaskas E., Manika A., Markopoulou M., Kaprinis G., et al. (2002).  Relationship of age and psychosocial factors with biological ratings in patients with end-stage renal disease undergoing dialysis. Aging Clinical and Experimental Research. 14(5), 354 - 360.
Manika, A., Kontos F., Papavasileiou A., Papaventsis D., Sionidou M., & Kioumis I. (2021).  Severe Pulmonary Disease Caused by Mycolicibacter kumamotonensis.. Emerg Infect Dis. 27(3), 962-964.
Kipourou, M., Begou O., Manika A., Ismailos G., Kontou P., Pitsiou G., et al. (2023).  Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation. Antibiotics. 12(2), 307.
Manika, A., Diamantea F., Tsakona A., Kakolyris A., Sopiadou A., Kotoulas S-C., et al. (2023).  Use of cystic fibrosis inhaled medication before and after elexacaftor/tezacaftor/ivacaftor initiation. Journal of Cystic Fibrosis.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές